ストックスクリーナーアプリを入手
15.82
4.08%
0.62
アフターアワーズ：
15.82
前日終値:
$15.20
開ける：
$15.26
24時間の取引高:
1.05M
Relative Volume:
0.87
時価総額：
$796.38M
収益：
-
当期純損益:
$-156.39M
株価収益率:
-4.2873
EPS:
-3.69
ネットキャッシュフロー:
$-123.06M
1週間 パフォーマンス:
+17.53%
1か月 パフォーマンス:
+21.23%
6か月 パフォーマンス:
+36.26%
1年 パフォーマンス:
+22.92%
1日の値動き範囲:
$15.04
$15.85
1週間の範囲:
$13.47
$15.85
52週間の値動き範囲:
$7.30
$16.32
Kalvista Pharmaceuticals Inc Stock (KALV) Company Profile
名前
Kalvista Pharmaceuticals Inc
セクター
電話
(857) 999-0075
住所
55 CAMBRIDGE PARKWAY, CAMBRIDGE, MA
KALV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KALV
Kalvista Pharmaceuticals Inc
|
15.82 | 765.17M | 0 | -156.39M | -123.06M | -3.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Kalvista Pharmaceuticals Inc Stock (KALV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-31 | 開始されました | JMP Securities | Mkt Outperform |
| 2025-01-07 | 開始されました | TD Cowen | Buy |
| 2024-12-18 | 開始されました | BofA Securities | Buy |
| 2020-06-15 | 開始されました | H.C. Wainwright | Buy |
| 2019-07-29 | 開始されました | SVB Leerink | Outperform |
| 2019-03-20 | 開始されました | Needham | Buy |
| 2018-10-30 | 開始されました | Jefferies | Buy |
| 2018-09-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-08-31 | 開始されました | BTIG Research | Buy |
すべてを表示
Kalvista Pharmaceuticals Inc (KALV) 最新ニュース
Short interest data insights for KalVista Pharmaceuticals Inc.2025 Top Gainers & Daily Volume Surge Signals - Newser
Is KalVista Pharmaceuticals Inc. stock a smart retirement pickWeekly Stock Recap & Reliable Volume Spike Alerts - خودرو بانک
Aug Rallies: What is KalVista Pharmaceuticals Inc. s 5 year growth outlook2025 Big Picture & Capital Protection Trade Alerts - خودرو بانک
What analysts say about KalVista Pharmaceuticals Inc. stock2025 Risk Factors & Breakout Confirmation Trade Signals - خودرو بانک
Can KalVista Pharmaceuticals Inc. deliver consistent dividendsQuarterly Portfolio Summary & Long-Term Capital Growth Strategies - خودرو بانک
Can technical indicators confirm KalVista Pharmaceuticals Inc.’s reversalChart Signals & Safe Entry Point Alerts - Newser
KalVista Pharmaceuticals Inc. stock volume spike explainedGap Down & Real-Time Stock Entry Alerts - Newser
Does KalVista Pharmaceuticals (NASDAQ:KALV) Have A Healthy Balance Sheet? - 富途牛牛
Is KalVista Pharmaceuticals Inc. building a consolidation base2025 Earnings Surprises & Low Risk Entry Point Guides - Newser
What MACD and RSI say about KalVista Pharmaceuticals Inc.Analyst Downgrade & High Conviction Buy Zone Alerts - Newser
Is KalVista Pharmaceuticals (NASDAQ:KALV) A Risky Investment? - simplywall.st
Can volume confirm reversal in KalVista Pharmaceuticals Inc.2025 Market Trends & Low Drawdown Trading Techniques - Newser
Combining machine learning predictions for KalVista Pharmaceuticals Inc.Trend Reversal & Daily Volume Surge Signals - Newser
Evaluating KalVista Pharmaceuticals Inc. with trendline analysisMarket Volume Report & Risk Adjusted Swing Trade Ideas - Newser
Can KalVista Pharmaceuticals Inc. maintain sales growthEarnings Growth Summary & Stepwise Entry and Exit Trade Signals - خودرو بانک
KalVista Pharmaceuticals to Provide Operational Update and Fiscal Quarter Financial Results on September 11, 2025 - Business Wire
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
KalVista Q1 Earnings On DeckWill Sebetralstat's EU Nod Be The Catalyst It Needs? - RTTNews
Institutional scanner results for KalVista Pharmaceuticals Inc.Wall Street Watch & High Accuracy Swing Entry Alerts - Newser
Applying Elliott Wave Theory to KalVista Pharmaceuticals Inc.Weekly Trade Review & Daily Chart Pattern Signal Reports - Newser
What’s the recovery path for long term holders of KalVista Pharmaceuticals Inc.2025 Volatility Report & Free Weekly Watchlist of Top Performers - Newser
What is KalVista Pharmaceuticals Inc. s debt to equity ratioDip Buying & Safe Entry Point Identification - خودرو بانک
Price action breakdown for KalVista Pharmaceuticals Inc.Jobs Report & Verified Momentum Stock Ideas - Newser
How high can KalVista Pharmaceuticals Inc. stock goMarket Growth Review & Weekly Watchlist for Hot Stocks - Newser
Price momentum metrics for KalVista Pharmaceuticals Inc. explainedSwing Trade & Weekly Top Performers Watchlists - Newser
Chart based exit strategy for KalVista Pharmaceuticals Inc.2025 Top Decliners & AI Driven Stock Reports - Newser
How institutional ownership impacts KalVista Pharmaceuticals Inc. stock2025 Top Gainers & Consistent Profit Alerts - Newser
KALVISTA PHARMACEUTICALS Earnings Preview: Recent $KALV Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
KalVista Pharmaceuticals Inc. Recovers — But Is It Sustainable getLinesFromResByArray error: size == 0 - 강소기업뉴스
Analyzing recovery setups for KalVista Pharmaceuticals Inc. investorsTrade Volume Report & Technical Entry and Exit Tips - Newser
Real time social sentiment graph for AFRIWJuly 2025 Review & Technical Pattern Recognition Alerts - Newser
Sentiment analysis tools applied to KalVista Pharmaceuticals Inc.July 2025 Volume & Fast Gaining Stock Reports - Newser
Heatmap Data Shows High Activity in KalVista Pharmaceuticals Inc. Sector2025 Pullback Review & Growth Oriented Trading Recommendations - beatles.ru
How to build a dashboard for KalVista Pharmaceuticals Inc. stockWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
Kalvista Pharmaceuticals Inc (KALV) 財務データ
収益
当期純利益
現金流量
EPS
1.40%
大文字化:
|
ボリューム (24 時間):